Literature DB >> 23830684

Intracortical excitatory and thalamocortical boutons are intact in primary auditory cortex in schizophrenia.

Caitlin E Moyer1, Kristen M Delevich, Kenneth N Fish, Josephine K Asafu-Adjei, Allan R Sampson, Karl-Anton Dorph-Petersen, David A Lewis, Robert A Sweet.   

Abstract

Schizophrenia is associated with auditory processing impairments that could arise as a result of primary auditory cortex excitatory circuit pathology. We have previously reported a deficit in dendritic spine density in deep layer 3 of primary auditory cortex in subjects with schizophrenia. As boutons and spines can be structurally and functionally co-regulated, we asked whether the densities of intracortical excitatory or thalamocortical presynaptic boutons are also reduced. We studied 2 cohorts of subjects with schizophrenia and matched controls, comprising 27 subject pairs, and assessed the density, number, and within-bouton vesicular glutamate transporter (VGluT) protein level of intracortical excitatory (VGluT1-immunoreactive) and thalamocortical (VGluT2-immunoreactive) boutons in deep layer 3 of primary auditory cortex using quantitative confocal microscopy and stereologic sampling methods. We found that VGluT1- and VGluT2-immunoreactive puncta densities and numbers were not altered in deep layer 3 of primary auditory cortex of subjects with schizophrenia. Our results indicate that reduced dendritic spine density in primary auditory cortex of subjects with schizophrenia is not matched by a corresponding reduction in excitatory bouton density. This suggests excitatory boutons in primary auditory cortex in schizophrenia may synapse with structures other than spines, such as dendritic shafts, with greater frequency. The discrepancy between dendritic spine reduction and excitatory bouton preservation may contribute to functional impairments of the primary auditory cortex in subjects with schizophrenia.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Postmortem human tissue; Primary auditory cortex; Quantitative microscopy; Stereology; VGluT1; VGluT2

Mesh:

Substances:

Year:  2013        PMID: 23830684      PMCID: PMC3756893          DOI: 10.1016/j.schres.2013.06.024

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  55 in total

1.  Glutamatergic modulation of auditory information processing in the human brain.

Authors:  Handan Gunduz-Bruce; Robert M G Reinhart; Brian J Roach; Ralitza Gueorguieva; Stephen Oliver; Deepak C D'Souza; Judith M Ford; John H Krystal; Daniel H Mathalon
Journal:  Biol Psychiatry       Date:  2011-10-29       Impact factor: 13.382

Review 2.  Complementary distribution of vesicular glutamate transporters in the central nervous system.

Authors:  Takeshi Kaneko; Fumino Fujiyama
Journal:  Neurosci Res       Date:  2002-04       Impact factor: 3.304

Review 3.  The chandelier neuron in schizophrenia.

Authors:  David A Lewis
Journal:  Dev Neurobiol       Date:  2011-01-01       Impact factor: 3.964

4.  Associated deficits in mismatch negativity generation and tone matching in schizophrenia.

Authors:  D C Javitt; A Shelley; W Ritter
Journal:  Clin Neurophysiol       Date:  2000-10       Impact factor: 3.708

5.  Vesicular glutamate transporter mRNA expression in the medial temporal lobe in major depressive disorder, bipolar disorder, and schizophrenia.

Authors:  Akihito Uezato; James H Meador-Woodruff; Robert E McCullumsmith
Journal:  Bipolar Disord       Date:  2009-11       Impact factor: 6.744

6.  Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites.

Authors:  Robert T Fremeau; Kaiwen Kam; Tayyaba Qureshi; Juliette Johnson; David R Copenhagen; Jon Storm-Mathisen; Farrukh A Chaudhry; Roger A Nicoll; Robert H Edwards
Journal:  Science       Date:  2004-04-29       Impact factor: 47.728

7.  Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia.

Authors:  Dean F Salisbury; Noriomi Kuroki; Kiyoto Kasai; Martha E Shenton; Robert W McCarley
Journal:  Arch Gen Psychiatry       Date:  2007-05

8.  Distribution of choline acetyltransferase-, serotonin-, dopamine-beta-hydroxylase-, tyrosine hydroxylase-immunoreactive fibers in monkey primary auditory cortex.

Authors:  M J Campbell; D A Lewis; S L Foote; J H Morrison
Journal:  J Comp Neurol       Date:  1987-07-08       Impact factor: 3.215

9.  Progressive gray matter reduction of the superior temporal gyrus during transition to psychosis.

Authors:  Tsutomu Takahashi; Stephen J Wood; Alison R Yung; Bridget Soulsby; Patrick D McGorry; Michio Suzuki; Yasuhiro Kawasaki; Lisa J Phillips; Dennis Velakoulis; Christos Pantelis
Journal:  Arch Gen Psychiatry       Date:  2009-04

10.  Evidence for a decrease in basilar dendrites of pyramidal cells in schizophrenic medial prefrontal cortex.

Authors:  Kevin Broadbelt; William Byne; Liesl B Jones
Journal:  Schizophr Res       Date:  2002-11-01       Impact factor: 4.939

View more
  14 in total

1.  Loss of Microtubule-Associated Protein 2 Immunoreactivity Linked to Dendritic Spine Loss in Schizophrenia.

Authors:  Micah A Shelton; Jason T Newman; Hong Gu; Allan R Sampson; Kenneth N Fish; Matthew L MacDonald; Caitlin E Moyer; James V DiBitetto; Karl-Anton Dorph-Petersen; Peter Penzes; David A Lewis; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2015-01-30       Impact factor: 13.382

Review 2.  The glutamate hypothesis of schizophrenia: evidence from human brain tissue studies.

Authors:  Wei Hu; Matthew L MacDonald; Daniel E Elswick; Robert A Sweet
Journal:  Ann N Y Acad Sci       Date:  2014-10-14       Impact factor: 5.691

3.  Synaptic Proteome Alterations in the Primary Auditory Cortex of Individuals With Schizophrenia.

Authors:  Matthew L MacDonald; Megan Garver; Jason Newman; Zhe Sun; Joseph Kannarkat; Ryan Salisbury; Jill Glausier; Ying Ding; David A Lewis; Nathan Yates; Robert A Sweet
Journal:  JAMA Psychiatry       Date:  2020-01-01       Impact factor: 21.596

4.  Altered glutamate protein co-expression network topology linked to spine loss in the auditory cortex of schizophrenia.

Authors:  Matthew L MacDonald; Ying Ding; Jason Newman; Scott Hemby; Peter Penzes; David A Lewis; Nathan A Yates; Robert A Sweet
Journal:  Biol Psychiatry       Date:  2014-11-26       Impact factor: 13.382

5.  GABA bouton subpopulations in the human dentate gyrus are differentially altered in mesial temporal lobe epilepsy.

Authors:  Ahmad Alhourani; Kenneth N Fish; Thomas A Wozny; Vivek Sudhakar; Ronald L Hamilton; R Mark Richardson
Journal:  J Neurophysiol       Date:  2019-12-04       Impact factor: 2.714

6.  Selective Loss of Smaller Spines in Schizophrenia.

Authors:  Matthew L MacDonald; Jamil Alhassan; Jason T Newman; Michelle Richard; Hong Gu; Ryan M Kelly; Alan R Sampson; Kenneth N Fish; Peter Penzes; Zachary P Wills; David A Lewis; Robert A Sweet
Journal:  Am J Psychiatry       Date:  2017-03-31       Impact factor: 18.112

Review 7.  Unusual Molecular Regulation of Dorsolateral Prefrontal Cortex Layer III Synapses Increases Vulnerability to Genetic and Environmental Insults in Schizophrenia.

Authors:  Amy F T Arnsten; Elizabeth Woo; Shengtao Yang; Min Wang; Dibyadeep Datta
Journal:  Biol Psychiatry       Date:  2022-02-12       Impact factor: 12.810

Review 8.  Auditory dysfunction in schizophrenia: integrating clinical and basic features.

Authors:  Daniel C Javitt; Robert A Sweet
Journal:  Nat Rev Neurosci       Date:  2015-09       Impact factor: 34.870

9.  Developmental Trajectories of Auditory Cortex Synaptic Structures and Gap-Prepulse Inhibition of Acoustic Startle Between Early Adolescence and Young Adulthood in Mice.

Authors:  Caitlin E Moyer; Susan L Erickson; Kenneth N Fish; Edda Thiels; Peter Penzes; Robert A Sweet
Journal:  Cereb Cortex       Date:  2015-03-10       Impact factor: 5.357

10.  Thalamocortical-auditory network alterations following cuprizone-induced demyelination.

Authors:  Nikoo Ghaffarian; Masoud Mesgari; Manuela Cerina; Kerstin Göbel; Thomas Budde; Erwin-Josef Speckmann; Sven G Meuth; Ali Gorji
Journal:  J Neuroinflammation       Date:  2016-06-22       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.